Aterian (ATER) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
15 May, 2026Executive summary
Entered agreements to sell marquee brands for $18M and issue $7M in preferred stock, fundamentally restructuring operations and capital position.
Proceeds intended to pay down debt and provide working capital for remaining brands, with new majority control by a single investor post-transaction.
Substantial doubt exists about ability to continue as a going concern pending transaction closure and stockholder approval.
Financial highlights
Net revenue from continuing operations fell 72% year-over-year to $18K; discontinued operations revenue dropped 18.8% to $12.4M.
Net loss for the quarter was $6.1M, compared to $3.9M in the prior year period.
Gross profit margin for discontinued operations improved to 64.3% from 60.9% year-over-year.
Operating loss from continuing operations was $3.2M; discontinued operations posted a $2.7M loss, including a $3.4M non-cash impairment.
Cash used in operating activities was $0.4M, with $2.1M used in financing activities and $4K in investing.
Outlook and guidance
Future viability depends on successful closure of asset and stock sales; failure would require alternative strategies or drastic cost reductions.
Ongoing macroeconomic pressures, tariffs, and geopolitical instability expected to increase costs and impact margins.
Management plans to hold a special stockholder meeting by July 20, 2026, to seek transaction approvals.
Latest events from Aterian
- Shareholders will vote on major asset sale, strategic investment, and capital structure changes.ATER
Proxy filing18 Jun 2026 - Special Meeting to vote on asset sale, director elections, and major capital structure changes.ATER
Proxy filing11 Jun 2026 - Vote on asset sale, $7M investment, board overhaul, and major capital changes recommended FOR.ATER
Proxy filing9 Jun 2026 - Approval sought for asset sale, new investment, board overhaul, and major capital structure changes.ATER
Proxy filing8 Jun 2026 - Asset sale, recapitalization, and board overhaul proposed to address liquidity and strategic challenges.ATER
Proxy filing1 Jun 2026 - Asset sale, major investment, board overhaul, and capital structure changes recommended for approval.ATER
Proxy filing15 May 2026 - Asset sale and strategic investment will transfer control to David Lazar, pending shareholder approval.ATER
Proxy filing29 Apr 2026 - Revenue dropped 30% and net loss widened as tariffs and weak demand pressured results.ATER
Q4 202523 Mar 2026 - Q2 guidance raised and new leadership named; profitability targeted for H2 2024.ATER
Investor Update3 Feb 2026